Oren Livne

Oren Livne

Baker & McKenzie LLP


Oren Livne is a partner in the Corporate & Securities Practice Group and the Life Sciences Industry Group. Prior to beginning his law career, Oren co-founded a university technology transfer office and managed its licensing operations, which, together with his M.B.A, from New York University's Leonard N. Stern School of Business, provide a unique business perspective that he leverages for the benefit of the firm's clients.

Practice Focus

Oren Livne counsels clients from startups to multinationals on variety of corporate and transactional matters globally, including complex license and collaboration agreements, joint ventures, spin outs, commercial contracts, mergers and acquisitions, and other intellectual property focused transactions. His clients include pharmaceutical, biotech, medical device, consumer product, and technology companies as well as private equity firms. Oren is a guest lecturer at New York University law and business classes and has authored several licensing and intellectual property articles.

Representative Legal Matters

  • Abbott in its agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions that combine Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management.

  • GSK Consumer Healthcare in its collaboration with Mammoth Biosciences to develop a rapid, handheld CRISPR-based test to detect novel coronavirus infections.

  • Galapagos in its collaboration with Ryvu Therapeutics focused on the discovery and development of novel small molecule drugs in inflammation.

  • Abbott in its collaboration with Insulet to integrate next-generation glucose sensing and automated insulin delivery technologies.

  • CytoSorbents in its agreement with China Medical System to bring CytoSorb® to mainland China to treat critically-ill patients with COVID-19 coronavirus infection. 

  • AbbVie in the expansion of its TriTAC discovery collaboration agreement with Harpoon.

  • AbbVie in its exclusive license agreement with Disc Medicine granting worldwide rights to a series of hemojuvelin antagonist monoclonal antibodies.

  • Abbott in its collaboration with Omada Health to offer an integrated digital health and coaching experience for people with type 2 diabetes.

  • Mithra in its landmark license and supply agreement with Mayne Pharma for Estelle® in the United States, for license fees of at least USD 295 million and a 9.6% equity stake across two tranches.

  • Galapagos in its transformative USD 5.1 billion research and development collaboration with Gilead.

Professional Honors

  • Dealmakers Award to Baker McKenzie Life Sciences Group, NJLJ Professional Excellence, 2020
  • Notable Practitioner, IFLR 1000, 2020
  • Rising Star, Super Lawyers New Jersey, 2020
  • Rising Star, Healthcare: Life Sciences, The Legal 500 United States, 2019
  • Certified Licensing Professional, 2008-2020

Professional Associations and Memberships

  • New York State Bar Association
  • New Jersey State Bar Association
  • Licensing Executives Society


  • New York~United States
  • New Jersey~United States
  • U.S. Patent and Trademark Office~United States


  • New York University (MBA with distinction) (2012)
  • New York University School of Law (JD) (2012)
  • Rutgers University (BS Chemical Engineering with Highest Honors) (1996)


  • English